On Autism’s Trail
A new microarray that can simultaneously detect 500,000 or more specific genetic variations, covering almost every gene in the genome, will provide better insights into the complex genetic bases of many illnesses. Using the chip from Santa Clara, CA-based Affymetrix (a similar one is made by San Diego-based Illumina), researchers worldwide are seeking genetic causes of diseases such as autism, diabetes, and Alzheimer’s. Below is a sampling of these efforts. Emily Singer
Disease
U.S. sufferers
Status
Autism
1 million to 1.5 million
Genetic data from 3,700 people with autism are now being analyzed.
Alzheimer’s
4.5 million
Genetic data have been collected from 1,645 Alzheimer’s patients. Results from analysis are expected late this year or in early 2007.
Type 1 and type 2
diabetes
20.7 million
Early results from a study of 2,000 sufferers of each diabetes type are expected by early 2007.
Hypertension
65 million
Early results from a study of 2,000 sufferers are expected by early 2007.
Keep Reading
Most Popular
DeepMind’s cofounder: Generative AI is just a phase. What’s next is interactive AI.
“This is a profound moment in the history of technology,” says Mustafa Suleyman.
What to know about this autumn’s covid vaccines
New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.
Human-plus-AI solutions mitigate security threats
With the right human oversight, emerging technologies like artificial intelligence can help keep business and customer data secure
Next slide, please: A brief history of the corporate presentation
From million-dollar slide shows to Steve Jobs’s introduction of the iPhone, a bit of show business never hurt plain old business.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.